1. Home
  2. BTOC vs ALXO Comparison

BTOC vs ALXO Comparison

Compare BTOC & ALXO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

BTOC

Armlogi Holding Corp.

HOLD

Current Price

$0.70

Market Cap

43.6M

Sector

N/A

ML Signal

HOLD

Logo ALX Oncology Holdings Inc.

ALXO

ALX Oncology Holdings Inc.

HOLD

Current Price

$1.47

Market Cap

79.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BTOC
ALXO
Founded
2020
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
43.6M
79.7M
IPO Year
2024
2020

Fundamental Metrics

Financial Performance
Metric
BTOC
ALXO
Price
$0.70
$1.47
Analyst Decision
Strong Buy
Analyst Count
0
6
Target Price
N/A
$3.30
AVG Volume (30 Days)
430.0K
255.4K
Earning Date
11-13-2025
11-07-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$197,399,541.00
N/A
Revenue This Year
$34.89
N/A
Revenue Next Year
$14.53
N/A
P/E Ratio
N/A
N/A
Revenue Growth
17.35
N/A
52 Week Low
$0.41
$0.40
52 Week High
$5.84
$2.27

Technical Indicators

Market Signals
Indicator
BTOC
ALXO
Relative Strength Index (RSI) 63.05 51.75
Support Level $0.56 $1.29
Resistance Level $0.68 $1.57
Average True Range (ATR) 0.05 0.11
MACD 0.02 0.02
Stochastic Oscillator 88.46 67.50

Price Performance

Historical Comparison
BTOC
ALXO

About BTOC Armlogi Holding Corp.

Armlogi Holding Corp is a fast-growing U.S.-based warehousing and logistics service provider that offers a comprehensive package of supply-chain solutions relating to warehouse management and order fulfillment. The company provides one-stop warehousing and logistics services to cross-border e-commerce merchants outside the U.S. who seek to sell in the U.S. market. The warehouses are equipped with automated sorting systems, heavy-duty forklifts, and pallets and trays that are suitable for processing bulky items. The services of the company include customs brokerage services, transportation of merchandise to U.S. warehouses, and warehouse management and order fulfillment services.

About ALXO ALX Oncology Holdings Inc.

ALX Oncology Holdings Inc is a clinical-stage immuno-oncology company focused on helping patients fight cancer by developing a pipeline of product candidates based on expertise in protein engineering and oncology led by the CD47 blocker, evorpacept, currently in phase 1 and 2 clinical trials. Cancer cells leverage CD47, a cell surface protein, as a don't eat me signal to evade detection by the immune system. The company is developing a next-generation checkpoint inhibitor designed to have a high affinity for CD47 and to avoid the limitations caused by hematologic toxicities inherent in other CD47 blocking approaches.

Share on Social Networks: